Why the study?
Are body adiposity markers associated with a high 10-year risk of fatal CHD in patients with type 2 diabetes?
Population
420 patients with type 2 diabetes, mean age 61.9 ± 9.5 years, 53.5% females, HbA1c 7.6 ± 1.6%.
Design
Cross-sectional
Authors
Loading...
Conicity index shows strongest adiposity marker association with high fatal CHD risk in T2D; hypothesis-generating, should not yet change practice.
Are body adiposity markers associated with a high 10-year risk of fatal CHD in patients with type 2 diabetes?
The conicity index is the body adiposity marker most strongly associated with a high estimated 10-year risk of fatal CHD in patients with type 2 diabetes.
Tonding et al. (2014) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: